Home / Research library / Prostamax
Prostamax: molecular data, studies & sources
Prostamax is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
- Molecular formula (MF)
- C20H33N5O9
- Molecular weight (MW)
- 487.5 g/mol
- PubChem compound ID
- 9848296
- Record title
- Prostamax
Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.
Source: PubChem CID 9848296 · retrieved 2026-09-21

Chemical identifiers and source data
- IUPAC name
- (2S)-1-[(2S)-3-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-2,6-diaminohexanoyl]amino]butanoyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
- InChIKey
- WUCUNGRTSFLCLI-XUXIUFHCSA-N
- SMILES
- C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O
Identifiers & sequence
- PubChem CID
- 9848296
- InChIKey
- WUCUNGRTSFLCLI-XUXIUFHCSA-N
Peptide sequence · 4 residues (one-letter code; X marks a residue without a one-letter code)
KEDP
Condensed notation with terminal groups and non-standard residues
H-Lys-Glu-Asp-Pro-OH
Source: PubChem Biologic Line Notation. A reference sequence for the record, not an analysis of a supplied batch.
Calculated molecular descriptors
| Monoisotopic (exact) mass | 487.2278 Da |
|---|---|
| Heavy atoms | 34 |
| Hydrogen-bond donors | 7 |
| Hydrogen-bond acceptors | 8 |
| Rotatable bonds | 15 |
| Topological polar surface area | 242.4 Ų |
| Calculated logP (Crippen) | -2.17 |
| Rings | 1 |
| Stereocenters | 4 |
| Formal charge | 0 |
Computed with RDKit from the published SMILES (Crippen logP, topological polar surface area). Calculated descriptors are not measured properties of a supplied batch.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Prostamax as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
No registered study naming this compound was matched. This is a documented gap in registry coverage, not proof that no study exists.
Registry check 2026-10-01 · Run this search on ClinicalTrials.gov
Human intervention studies
Selected studies in which participants received Prostamax, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
- Research publication · design requires review
[The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ].
Meskhi T, Khachidze D, Barbakadze Sh et al. · Biofizika · 2004
PMID 15612551
- Research publication · design requires review
Microcalorimetric study of human blood lymphocytes culture at presence of copper, cadmium and prostamax.
Kiladze M, Gorgoshidze M, Monaselidze J et al. · Georgian medical news · 2009
PMID 19359734
- Research publication · design requires review
[Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)].
Dzhokhadze TA, Buadze TZh, Gaĭozishvili MN et al. · Georgian medical news · 2012
PMID 23221144
- Preclinical / laboratory research
[The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats].
Zakutskiĭ AN, Chalisova NI, Ryzhak GA et al. · Advances in gerontology = Uspekhi gerontologii · 2006
Organotypic tissue cultures from young and aged rats. Tissue-culture responses do not demonstrate patient benefit.
PMID 17152728
- Research publication · design requires review
Effects of short peptides on lymphocyte chromatin in senile subjects.
Khavinson VKh, Lezhava TA, Malinin VV et al. · Bulletin of experimental biology and medicine · 2004
PMID 15085253 · DOI: 10.1023/b:bebm.0000024393.40560.05
Prostamax supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Prostamax for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 20mg Vial1 recorded offers | 20mg Vial · $55.00Checked Nov 6, 2026Supplier listing, Prostamax 20mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 20mg Vial1 recorded offers | 20mg Vial · $64.99Checked Nov 3, 2026Supplier listing, Prostamax 20mg Vial, Cenexa Labs, opens in a new tab |
| American PeptidesUSD | 20mg Vial1 recorded offers | 20mg Vial · $60.00Recorded out of stock · Checked Nov 6, 2026Supplier listing, Prostamax 20mg Vial, American Peptides, opens in a new tab |
Reference sources & further reading
- PubChem compound record 9848296 — chemical identity and structure.
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Related research profiles
Bronchogen
C18H30N4O9
446.5 g/mol · PubChem CID 11690869
6 selected publications · 0 human intervention studies
Cardiogen
Molecular identity needs further verification
1 selected publication · 0 human intervention studies
Cartalax
C12H19N3O8
333.29 g/mol · PubChem CID 87815447
0 selected publications · 0 human intervention studies
Chonluten
C11H17N3O8
319.27 g/mol · PubChem CID 194641
1 selected publication · 0 human intervention studies
Cortagen
C17H26N4O9
430.4 g/mol · PubChem CID 18439621
5 selected publications · 0 human intervention studies
Epithalon
C14H22N4O9
390.35 g/mol · PubChem CID 219042
4 selected publications · 1 human intervention study